help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larsen, P. J.
Right arrow Articles by Jessop, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larsen, P. J.
Right arrow Articles by Jessop, D. S.

Endocrinology, Vol 134, 1635-1639, Copyright © 1994 by Endocrine Society


ARTICLES

Neuropeptide-Y potentiates the secretion of vasopressin from the neurointermediate lobe of the rat pituitary gland

PJ Larsen, KE Jukes, HS Chowdrey, SL Lightman and DS Jessop
Department of Anatomy, University of Copenhagen, Denmark.

Neuropeptide-Y (NPY) is colocalized with vasopressin and oxytocin in magnocellular neurons of the hypothalamo-neurohypophysial system, and a very high density of NPY-binding sites is present within the neurohypophysis. To investigate the possibility that NPY exerts a modulatory role on the release of neurohypophysial hormones, we have studied the actions of NPY on potassium-evoked release of vasopressin and oxytocin from the rat neurointermediate lobe in vitro. NPY dose- dependently potentiated vasopressin release evoked by high extracellular potassium (56 mM), with a maximal enhancement of 223% (10(-7) M NPY). A similar effect was obtained with the Y2-selective agonist NPY-(13-36). In contrast, no effect on the potassium-evoked release of oxytocin was observed at this concentration. In the absence of Ca2+ in the incubation medium, NPY did not potentiate vasopressin secretion, indicating that the effect of NPY on potassium-evoked secretion of neurohypophysial vasopressin is critically dependent on extracellular calcium ions. The number of neurohypophysial NPY-binding sites is drastically down-regulated in animals subjected to chronic osmotic stimulation. In the present study, it was observed that the potentiating effect of NPY on vasopressin secretion was completely abolished in neurointermediate lobes recovered from animals that had been drinking 2% NaCl for 12 days, reflecting the concomitant down- regulation of neurohypophysial NPY-binding sites observed during this state. Finally, it was confirmed that stimulation by high K+ significantly evoked the release of endogenous NPY from neurointermediate lobes of the pituitary gland. The present results provide evidence that NPY selectively and potently enhances evoked vasopressin secretion. Considering the coexistence of the two neuropeptides in magnocellular hypothalamo-neurohypophysial neurons, this action is likely to be part of an autostimulatory feedforward loop. NPY may be an important component in the mechanisms associated with the control of body fluid homeostasis.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Michalkiewicz, T. Michalkiewicz, D. L. Kreulen, and S. J. McDougall
Increased blood pressure responses in neuropeptide Y transgenic rats
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R417 - R426.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. P. H. Burbach, S. M. Luckman, D. Murphy, and H. Gainer
Gene Regulation in the Magnocellular Hypothalamo-Neurohypophysial System
Physiol Rev, July 1, 2001; 81(3): 1197 - 1267.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. R. Kapoor and C. D. Sladek
Substance P and NPY differentially potentiate ATP and adrenergic stimulated vasopressin and oxytocin release
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R69 - R78.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. J. Larsen, M. Tang-Christensen, and D. S. Jessop
Central Administration of Glucagon-Like Peptide-1 Activates Hypothalamic Neuroendocrine Neurons in the Rat
Endocrinology, October 1, 1997; 138(10): 4445 - 4455.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Grouzmann, T. Buclin, M. Martire, C. Cannizzaro, B. Dorner, A. Razaname, and M. Mutter
Characterization of a Selective Antagonist of Neuropeptide Y at the Y2 Receptor. SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF A Y2 ANTAGONIST
J. Biol. Chem., March 21, 1997; 272(12): 7699 - 7706.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. Chen and A. N. van den Pol
Multiple NPY Receptors Coexist in Pre- and Postsynaptic Sites: Inhibition of GABA Release in Isolated Self-Innervating SCN Neurons
J. Neurosci., December 1, 1996; 16(23): 7711 - 7724.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society